Target Price | CHF94.16 |
Price | CHF78.40 |
Potential | 20.10% |
Number of Estimates | 25 |
25 Analysts have issued a price target Alcon 2026 . The average Alcon target price is CHF94.16. This is 20.10% higher than the current stock price. The highest price target is CHF105.82 34.98% , the lowest is CHF79.63 1.57% . | |
A rating was issued by 29 analysts: 24 Analysts recommend Alcon to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Alcon stock has an average upside potential 2026 of 20.10% . Most analysts recommend the Alcon stock at Purchase. |
25 Analysts have issued a sales forecast Alcon 2025 . The average Alcon sales estimate is CHF9.2b . This is 5.38% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF9.7b 11.15% , the lowest is CHF9.0b 2.88% .
This results in the following potential growth metrics:
2024 | CHF8.7b | 2.73% |
---|---|---|
2025 | CHF9.2b | 5.39% |
2026 | CHF9.9b | 7.17% |
2027 | CHF10.5b | 6.38% |
2028 | CHF11.2b | 6.63% |
2029 | CHF11.9b | 6.59% |
18 Analysts have issued an Alcon EBITDA forecast 2025. The average Alcon EBITDA estimate is CHF2.5b . This is 5.78% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF2.7b 14.83% , the lowest is CHF2.4b 1.48% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF2.3b | 7.91% |
---|---|---|
2025 | CHF2.5b | 5.72% |
2026 | CHF2.8b | 12.33% |
2027 | CHF3.1b | 10.37% |
2028 | CHF3.3b | 7.97% |
2029 | CHF3.4b | 4.37% |
2024 | 26.69% | 5.05% |
---|---|---|
2025 | 26.77% | 0.31% |
2026 | 28.06% | 4.82% |
2027 | 29.11% | 3.74% |
2028 | 29.47% | 1.24% |
2029 | 28.86% | 2.07% |
19 Alcon Analysts have issued a net profit forecast 2025. The average Alcon net profit estimate is CHF941m . This is 5.07% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.2b 28.87% , the lowest is CHF663m 25.94% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF895m | 1.69% |
---|---|---|
2025 | CHF941m | 5.07% |
2026 | CHF1.2b | 26.28% |
2027 | CHF1.4b | 17.61% |
2028 | CHF1.6b | 14.45% |
2029 | CHF1.7b | 7.27% |
2024 | 10.26% | 1.01% |
---|---|---|
2025 | 10.23% | 0.26% |
2026 | 12.05% | 17.79% |
2027 | 13.32% | 10.54% |
2028 | 14.30% | 7.36% |
2029 | 14.39% | 0.63% |
19 Analysts have issued a Alcon forecast for earnings per share. The average Alcon EPS is CHF1.90 . This is 4.97% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF2.33 28.73% , the lowest is CHF1.34 25.97% .
This results in the following potential growth metrics and future valuations:
2024 | CHF1.81 | 1.69% |
---|---|---|
2025 | CHF1.90 | 4.97% |
2026 | CHF2.40 | 26.32% |
2027 | CHF2.82 | 17.50% |
2028 | CHF3.23 | 14.54% |
2029 | CHF3.47 | 7.43% |
Current | 45.15 | 6.84% |
---|---|---|
2025 | 43.00 | 4.76% |
2026 | 34.05 | 20.81% |
2027 | 28.95 | 14.98% |
2028 | 25.30 | 12.61% |
2029 | 23.58 | 6.80% |
Based on analysts' sales estimates for 2025, the Alcon stock is valued at an EV/Sales of 4.72 and an P/S ratio of 4.40 .
This results in the following potential growth metrics and future valuations:
Current | 4.98 | 5.06% |
---|---|---|
2025 | 4.72 | 5.15% |
2026 | 4.41 | 6.69% |
2027 | 4.14 | 6.00% |
2028 | 3.89 | 6.22% |
2029 | 3.65 | 6.18% |
Current | 4.63 | 6.80% |
---|---|---|
2025 | 4.40 | 5.10% |
2026 | 4.10 | 6.69% |
2027 | 3.86 | 6.00% |
2028 | 3.62 | 6.22% |
2029 | 3.39 | 6.18% |
Analyst | Rating | Action | Date |
---|---|---|---|
BTIG |
Buy
➜
Buy
|
Unchanged | Dec 22 2024 |
HSBC |
Buy
➜
Buy
|
Unchanged | Nov 24 2024 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Nov 18 2024 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Nov 18 2024 |
EQUITA SIM |
Buy
➜
Buy
|
Unchanged | Nov 14 2024 |
NEEDHAM & COMPANY INC. |
Buy
➜
Buy
|
Unchanged | Nov 12 2024 |
RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Nov 12 2024 |
Analyst Rating | Date |
---|---|
Unchanged
BTIG:
Buy
➜
Buy
|
Dec 22 2024 |
Unchanged
HSBC:
Buy
➜
Buy
|
Nov 24 2024 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Nov 18 2024 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Nov 18 2024 |
Unchanged
EQUITA SIM:
Buy
➜
Buy
|
Nov 14 2024 |
Unchanged
NEEDHAM & COMPANY INC.:
Buy
➜
Buy
|
Nov 12 2024 |
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Nov 12 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.